ABSTRACT
The Coronavirus disease (COVID-19) pandemic highlighted the need for trustworthy data and science to guide the response of authorities, institutions and the public. Data in isolation lacks purpose or value and may pose little danger to its custodian from privacy or from the ability to manipulate it. The urgent and pressing need for a cure is forcing researchers and scientists to put the benefit in front of the legalities: sharing models, research and analytics accelerating science ahead of regulation. In the number of months since the pandemic recorded its first case, open science has led to the isolation of the virus, a standardized list of symptoms, COVID-19's genome has been sequenced and shared, multiple formats of testing have evolved and the potential of global vaccines have been developed across multiple jurisdictions. Prior to the pandemic, science was largely publicly funded, but not publicly accessible.
